Our in vitro data are consistent with in vivo animal studies that oral apoA-I mimetic peptides upregulate in vivo IFNβ1 and MX1 levels in the lungs of mice with lung cancer [11]. The gene discussed is APOA1; the disease is lung carcinoma.